Simone Scuderi

Large multicenter study: "When grade group discordant between systematic & targeted biopsy, risk is intermediate. Current approach assigning highest grade should be abandoned ... consider de-escalating treatment when grade discordant." academic.oup.com/jnci/advance-a…

Grateful for the incredible experience at ERUS24 in Bordeaux! 🍷Always a pleasure to reconnect with old friends and mentors, and honored to receive the Best Video Abstract prize. Looking forward to London for ERUS25! 🤖@GGandaglia @_alelarcher @u_capitanio @UFalagario

Previously argued results of MRI studies (eg PRECISION) wouldn't be valid if oncologic risk differed grade-by-grade between systematic and MRI. More evidence this is true: risk lower if MRI grade>systematic @dr_coops @SigridCarlsson sciencedirect.com/science/articl…

Our novel risk classification integrates currently available preoperative tools & should assist physician in preoperative counseling of men candidates for radical treatment for #prostatecancer with ➕ lymph node uptake at PSMA-PET authors.elsevier.com/c/1hjyF9Cfv-xp… @GGandaglia @EAUYAUrology

Current Issue: Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer buff.ly/3JkfdZ5 @SimoneScuderi1 @GGandaglia @ArmandoStabile @F_Montorsi @Albert0Briganti @VickersBiostats #openscience

The implementation of 4Kscore in US urologic practice led to an estimated 45 000 fewer biopsies and nearly 13 000 fewer cancer diagnoses🌰🏹 @VickersBiostats sciencedirect.com/science/articl…

#AUA2023 Chicago was a blast! But sadly it also means that you Simone will leave our Trio of European uro-msk research fellows! How lucky we were to end up at the same time + same place! Fellowships only take 1-2 years but the friendships will last forever!😘

@SimoneScuderi1 discussing PCa stage migration and its potential implication due to more accurate imaging with PSMA PET

Big news! decisioncurveanalysis.org has been completely updated and revamped. Code, tutorials, guides, bibliographies, videos and more! Amazing job by @ShaunPorwal @statistishdan

Study shows benefit of PSMA-PET imaging before radical prostatectomy urologytimes.com/view/study-sho… #urology #urologist #prostatecancer @SimoneScuderi1

I'm running statistical coordinating center for a multicenter collaboration examining outcomes in men who had both systematic & targeted biopsy. Submitting institutions may access complete cleaned data set. DM . Email if you are interested in joining!

The prognostic impact of preop PSMA-PET on early onc outcomes in #prostatecancer pts treated with RP @SimoneScuderi1 #EAU23 @urotoday 📍 n=3,978 N0M0 pts 📍 Grp 1: n=3,518 pts staged w/ CI; Grp 2: n=273 pts staged w/ PSMA PET/CT 📍n=282 pts had early recurrence 📍MV LR: PSMA-PET assoc w/ lower risk of early recurrence (OR 0.61, 95%CI 0.42-0.88)

🔥Great News

We and @Uroweb are delighted to announce that Alberto Briganti @Albert0Briganti will replace @JimCatto as our new Editor in Chief of @EUplatinum Thank you to all the team who worked so hard to take us this far and we look forward to new horizons.

🔥 Just published on @EurUrolFocus: Impact of Early DVC Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial ➡️ Have a look at it here (50-days free access): authors.elsevier.com/a/1foRZ8Yy0LMy…

This is interesting, and perhaps pretty transformational. Evidence that what matters in prostate cancer is total amount of pattern 4. Ratio pattern 4 to pattern 3 (how we currently grade) not so helpful. sciencedirect.com/science/articl…

PSMA radioguided surgery has limited sensitivity for nodal metastases. Read more 👇 prostate.uroonco.uroweb.org/publication/pr… #prostatecancer @GGandaglia @elio_mazzone @ArmandoStabile @PellegrinoMD @cucchiara_v @SimoneScuderi1 @LeniRiccardo @GiorgioBre @FDeCobelli @roodvdb

Only the highest risk patients with adverse pathology after #prostatectomy have benefit of adjuvant radiotherapy versus early salvage. Read more 👇 prostate.uroonco.uroweb.org/publication/no… #prostatecancer @elio_mazzone @GGandaglia @SimoneScuderi1 @DanieleRaggi83 @AndreaNecchi @roodvdb

Standardising the Assessment of Patient-reported Outcome Measures in Localised PCa. A Systematic Review buff.ly/3womvFb @GGandaglia @eugeniaalleva @beyer_katharina @pellegrino_fra @FrancescoBarl20 @SimoneScuderi1 @drimranomar @SajMacLennan @philcornford @NDowJames

The impact of histological variants on the performance characteristics of 68Ga-PSMA PET/CT in the primary and recurrent setting. Presentation by @SimoneScuderi1 @SanRaffaeleMI. #AUA22 written coverage by @rksayyid @mcg_urology > bit.ly/3sH1Vh2 @AmerUrological